| 2025 Active Trans-NIH Requests for Applications (RFA's) | |
| RFA No. and Title | Status - Expiration |
|---|---|
| NS25-012 HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) | ACTIVE - JAN 16, 2027 |
| 2024 Active Requests for Applications (RFA's) | |
| RFA No. and Title | Status - Expiration |
|---|---|
| CA24-011 Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | ACTIVE - OCT 02, 2024 |
| CA24-009 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | ACTIVE - OCT 02, 2024 |
| 2023 Active Trans-NIH Program Announcements (PAs) | |
| PA No. and Title | Status - Expiration |
|---|---|
| PAR23-318 Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) | ACTIVE - MAR 21, 2026 |
| 2022 Active Trans-NIH Requests for Applications (RFA's) | |
| RFA No. and Title | Status - Expiration |
|---|---|
| OD22-010 Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required) | ACTIVE - JUL 02, 2024 |